News Vitura

Equities

VTR

FR0010309096

Real-time Euronext Paris Other stock markets 08:45:35 2024-04-25 am EDT			5-day change	1st Jan Change
7.45 ^EUR	+1.36%		-1.97%	-44.81%

Apr. 24	Vitura Health's Services Agreement with Code4 at Risk of Termination; Shares Plunge 31%	MT
Apr. 22	Vitura Health CEO to Step Down by June-End	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vitura Health's Services Agreement with Code4 at Risk of Termination; Shares Plunge 31%	Apr. 23	MT
Vitura Health CEO to Step Down by June-End	Apr. 21	MT
Vitura Health JV Commences Manufacture of GMP LaNeo MDMA; Shares Up 3%	Apr. 04	MT
Vitura: 2023 Annual Results	Mar. 27	BU
Vitura Health Joint Venture Supplies First Psilocybin for Patient Use Outside Trial	Mar. 17	MT
Vitura Health Appoints Independent Chair	Feb. 12	MT
Vitura SA Announces Changes to Board of Directors	Jan. 12	CI
Cronos Group Entering Australian Cannabis Market	Jan. 09	MT
Vitura Health Integrates Nicotine Vaping Products into Prescription Platform	Jan. 08	MT
Australian Shares Rally Following Christmas Holiday	Dec. 27	MT
Vitura Health Services' Canview Services Deal to Not be Extended; Shares Plunge 20%	Dec. 26	MT
Vitura Health's CanView Platform Achieves 2 Millionth Sale of Medicinal Cannabis	Dec. 10	MT
Middle East Tensions, Rate Hike Concerns Drag Down Australian Shares	23-10-19	MT
Vitura Health Signs Agreement to Acquire Doctors on Demand; Shares Jump 6%	23-10-18	MT
Vitura : 2023 Interim Financial Report	23-09-13	PU
Vitura : Press Release on the Publication of the 2023 Half-yearly Financial Report	23-09-12	PU
Vitura Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-12	CI
Vitura Health Secures WHO GDP Certification for Gold Coast and Melbourne Distribution Centers	23-07-26	MT
Vitura Signs Lease with Telco for French Office Space	23-07-04	MT
Vitura Leases 5,820 Sq.m of Space at Arcs De Seine	23-07-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer